openPR Logo
Press release

Global Geriatric Medicines Market Surges Toward US$ 1142.8 Billion by 2027, Enhancing the Quality of Senior Healthcare - TMR Study

10-09-2023 08:39 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Global Geriatric Medicines Market

Global Geriatric Medicines Market

Geriatric Medicines market is estimated to attain a valuation of US$ 1142.8 Billion by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6.9% during the forecast period, 2022-2027

The Global Geriatric Medicines Market is a vital and growing sector within the pharmaceutical and healthcare industries, focusing on medications and healthcare solutions specifically designed for the elderly population. As the world's elderly population continues to increase, the demand for geriatric medicines to address age-related health issues and improve the quality of life for older adults is on the rise. This research report provides a comprehensive analysis of the Global Geriatric Medicines Market, covering market dynamics, trends, growth drivers, challenges, and the competitive landscape.

Get a Sample Copy of the Geriatric Medicines Market Research Report (Use Corporate Mail Id for Quick Response) -https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2445

"Connect with our team of research specialists and unlock the optimal solution for driving your business growth"

Market Trends

• Polypharmacy Management
Efforts to reduce polypharmacy and minimize the number of medications prescribed to older adults while maintaining therapeutic efficacy.
• Personalized Medicine
The adoption of personalized medicine approaches for geriatric patients, tailoring treatments based on individual health profiles.
• Telemedicine and Remote Monitoring
The use of telemedicine and remote monitoring to provide healthcare services and monitor the health of elderly patients, especially during the COVID-19 pandemic.

Market Drivers

• Aging Population
The global increase in the elderly population is a primary driver for the Geriatric Medicines Market.
• Age-Related Diseases
The higher incidence of age-related diseases, such as cardiovascular diseases and diabetes, necessitates the development and use of geriatric medicines.

Market Challenges

• Polypharmacy
Managing multiple medications for elderly patients can lead to complications, including drug interactions and adverse effects.
• Healthcare Access
Ensuring access to geriatric medicines and healthcare services for elderly populations, particularly in underserved areas, can be challenging.

Inquire more about this report before purchase - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=2445

The report covers extensive competitive intelligence which includes the following data points:

- Business Overview
- Business Model
- Financial Data
- Financial - Existing
- Financial - Funding
- Product/Service Segment Analysis and specification
- Recent Development and Company Strategy Analysis
- SWOT Analysis

Competitor Analysis:

The significant players operating in the global Geriatric Medicines market are

Pfizer, Inc., Merck & Co., Inc., AstraZeneca, Bristol-Myers Squibb Company, Novartis AG

Market Segmentation -

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2022-2027.

This Report lets you identify the opportunities in Geriatric Medicines Market by means of a region:

• North America (the United States, Canada, and Mexico)
• Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
• South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)

Have Any Query? Ask To Analyst: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=2445

Recent Developments

Here are some recent developments of companies in the Geriatric Medicines Market, with the year:

year: 2023

• AstraZeneca (UK) announced the launch of its new drug, Imfinzi, for the treatment of advanced non-small cell lung cancer in elderly patients.
• Merck & Co. (US) announced the launch of its new drug, Keytruda, for the treatment of melanoma in elderly patients.
• Pfizer (US) announced the acquisition of Biohaven Pharmaceutical Holding Company (US), a company developing drugs for Alzheimer's disease, migraine, and other neurological disorders.

year: 2022

• Novartis (Switzerland) announced the launch of its new drug, Leqvio, for the treatment of Alzheimer's disease in early stages.
• Eli Lilly and Company (US) announced the launch of its new drug, Donanemab, for the treatment of Alzheimer's disease in early stages.
• Eisai Co., Ltd. (Japan) announced the launch of its new drug, Lecanemab, for the treatment of Alzheimer's disease in early stages.

Reasons to Buy The Geriatric Medicines Market Report: -

1.Regional report analysis highlighting the consumption of products/services in a region also shows the factors that influence the market in each region.

2.Reports provide opportunities and threats faced by suppliers in the Geriatric Medicines industry around the world.

The report shows regions and sectors with the fastest growth potential.

3.A competitive environment that includes market rankings of major companies, along with new product launches, partnerships, business expansions, and acquisitions.

4.The report provides an extensive corporate profile consisting of company overviews, company insights, product benchmarks, and SWOT analysis for key market participants.

5.This report provides the industry's current and future market outlook on the recent development, growth opportunities, drivers, challenges, and two regional constraints emerging in advanced regions.

More Trending Reports by Transparency Market Research -

Orthobiologics Market - https://www.globenewswire.com/news-release/2023/04/18/2649014/0/en/Orthobiologics-Market-Revenue-to-Cross-USD-13-8-Bn-by-2031-Transparency-Market-Research.html

ePharmacy Market- https://www.globenewswire.com/en/news-release/2023/04/21/2651813/0/en/ePharmacy-Market-Revenue-to-Cross-USD-362-8-Bn-by-2031-with-CAGR-of-19-2-TMR-Study.html

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Geriatric Medicines Market Surges Toward US$ 1142.8 Billion by 2027, Enhancing the Quality of Senior Healthcare - TMR Study here

News-ID: 3241878 • Views:

More Releases from Transparency Market Research

Paper-based Biofuel Cell Market to Reach USD 580.0 Mn by 2034, Driven by Rising Adoption of Wearable Electronics and Healthcare Applications |TMR
Paper-based Biofuel Cell Market to Reach USD 580.0 Mn by 2034, Driven by Rising …
The global Paper-based Biofuel Cell (PBFC) market is poised for substantial growth over the next decade, with its market value projected to rise from US$ 300.0 million in 2023 to US$ 580.0 million by 2034, reflecting a CAGR of 6.3% during the forecast period 2024-2034. The market is witnessing increased traction due to the expanding adoption of wearable electronic devices, rising prevalence of lifestyle diseases, and ongoing technological innovations in
Parcel Sortation System Market Projected to Reach USD 3.1 Billion by 2034, Driven by Surge in E-Commerce and Adoption of Automated Sorting Robots | TMR
Parcel Sortation System Market Projected to Reach USD 3.1 Billion by 2034, Drive …
The global Parcel Sortation System Market is witnessing steady growth, fueled by the rapid expansion of e-commerce, the rise in online shopping, and increasing adoption of automated parcel sorting robots. Valued at US$ 2.2 billion in 2023, the market is projected to reach US$ 3.1 billion by 2034, expanding at a CAGR of 3.1% during the forecast period from 2024 to 2034. Gain a preview of important insights from our Report
Paresthesia Treatment Market Forecast to Reach USD 8.0 Billion by 2034, Growing at a CAGR of 3.7% | TMR
Paresthesia Treatment Market Forecast to Reach USD 8.0 Billion by 2034, Growing …
The global Paresthesia Treatment Market is poised for steady growth over the forecast period 2024-2034, driven by rising incidence of neurological disorders, technological advancements in treatment modalities, and increasing awareness regarding early diagnosis and intervention. According to the latest industry analysis, the global paresthesia treatment market was valued at US$ 5.4 billion in 2023 and is projected to reach US$ 8.0 billion by 2034, expanding at a CAGR of 3.7%. Gain
Paroxysmal Nocturnal Hemoglobinuria Market Projected to Reach USD 11.7 Billion by 2034, Driven by Biologics and Geriatric Population Growth | TMR
Paroxysmal Nocturnal Hemoglobinuria Market Projected to Reach USD 11.7 Billion b …
The global Paroxysmal Nocturnal Hemoglobinuria (PNH) Market is poised for robust growth over the coming decade. Valued at US$ 3.8 billion in 2023, the market is projected to expand at a CAGR of 10.8% from 2024 to 2034, reaching US$ 11.7 billion by the end of 2034. The rise in geriatric population, coupled with the influx of biologics and advances in therapeutic strategies, is propelling the demand for effective management

All 5 Releases


More Releases for Medicine

Empowering Medicine through Student Nonprofit: Medicine Community & Research
Image: https://www.abnewswire.com/uploads/be780e491a4ae6bc377728149d5124cc.png (MCR's Logo by Jason Jiang) Many students dream of leading thousands and creating an impact in their community. Among these are Quang La (Founder), Adhrith (Co-founder), and Heymin Han (Co-founder) who came together to create Medicine Community & Research, a 501c3 nonprofit organization fiscally sponsored by The Hack Foundation. The mission of MCR revolves around 3 key things, a student community, a spread of medicine articles, and an organization that advocates for
Chinese Medicine Pot Market: Traditional Herbal Medicine Preparation and Brewing …
Global Chinese Medicine Pot Market Overview: The Chinese Medicine Pot market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others. In recent years, the Chinese Medicine Pot market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and globalization. This growth
Herbal Medicine Market 2019-2025: Market By Development, Regional Sales, Regiona …
In a recent study published by QY Research, titled Herbal Medicine, analysts offers an in-depth analysis of global Herbal Medicine market. The study analyses the various aspect of the market by studying its historic and forecast data. The research report provides Porters five force model, SWOT analysis, and PESTEL analysis of the market. The different areas covered in the report are market size, drivers and restrains, segment analysis, geographic outlook,
Tropical Medicine
Tropics are the most diverse regions on the earth . A large number of population live in this region where the weather varies throughout the year ( from scorching summer to chilly winter).This changing seasons induce the outbreaks of some fetal diseases known as tropical diseases which is unique only to the tropical areas. Malaria, Tuberculosis & AIDS are the major ones .Lack of sanitation, personal hygiene, proper
Sports Medicine Market 2018 | Top Most Players | Medstar Sports Medicine, Muelle …
Competitive Insights: The Sports Medicine Market is dominated by a few large players such as Arthrex, Inc, Smith & Nephew, DePuy Mitek Inc, and Stryker Corporation, who have consolidated the market controlling a share of more than 70% in 2016. These players consistently introduce innovative and technologically advanced products in the market to ensure a competitive advantage over the other players. Some other players operating in this industry are Medstar Sports
Indian Medicine
Dr.JRK's Siddha Research and Pharma is the herbal medicine in India, and has been in the business of good manufacturing practices. We strongly believing in intellectual asset creation through discovery, documentation and development of Indian systems of medicine. G7 capsules is the solution for Allergic Disorders the herbal medicine in Inida. Atopy or hyper sensitivity is the major problem in all countries, the problem manifest in multifold ways such as